Scott M. Palmer, MD, MHS
Year elected: 2012
Current membership category: Active
Duke University Medical Center
Suite 2073 MSRB 2
106 Research Drive
Durham, NC 27710
United States of America
Dr. Palmer is the Director of Pulmonary Research at the Duke Clinical Research Institute. He graduated from Oberlin College and completed residency training in Internal Medicine and fellowship training in Pulmonary and Critical Care Medicine at Duke. His primary research interests are centered on the areas of bronchiolitis obliterans and lung transplantation. His basic, translational and clinical studies have advanced the care of lung transplant recipients and enhanced our understanding of lung transplant rejection. He made the important observation that variations in innate pattern recognition receptors regulate lung rejection, thereby establishing the clinical importance of innate mechanisms in solid organ transplant rejection. His work has also highlighted the adverse effects of cytomegalovirus infection after lung transplantation. As a result, he led a multicenter randomized clinical trial that established a new and more effective clinical standard of care to prevent cytomegalovirus infection from developing. He continues to leverage translational human studies and rodent models to better understand the mechanisms that lead to lung rejection and develop clinically relevant approaches to modulate these processes and improve transplant outcomes.
Duke University School of Medicine (Primary)
Dr. Palmer is serving as the ASCI's Institutional Representative.